Panel discussion: Flow cytometry in bioanalysis
Thursday 26 March 2026
08:00 [PDT] 11:00 [EDT] 15:00 [GMT]
Alternative time zones
This Spotlight Panel discussion brings together leading experts to explore the transformative advancements shaping the future of bioanalytical flow cytometry. As a cornerstone technology in clinical research, flow cytometry is evolving rapidly, driven by innovations in instrumentation, data analytics and workflow harmonization.
This session will delve into key trends, challenges and emerging opportunities in the field, addressing topics such as high-parameter and spectral platforms, AI-driven data analysis tools, and challenges when implementing flow cytometry in global clinical trials. Attendees will gain insights into overcoming challenges like instrument variability, data harmonization, and outsourcing complexities, while also exploring emerging technologies such as automated rare event detection, imaging flow cytometry and cloud-based collaborative platforms. By emphasizing innovation, standardization and collaboration, this discussion aims to highlight the drivers shaping the future of bioanalytical flow cytometry and its impact on assay development, validation and clinical trial execution.
The conversation is shaped by survey data gathered throughout the Spotlight, with our experts sharing their insights and answering your questions in a live Q&A session.
Can’t see the form below? Register for the webinar here.
What will you learn?
- The assays, techniques and platforms currently used in flow cytometry research
- Major challenges of bioanalytical flow cytometry, including outsourcing research and implementation in global clinical trials
- AI/algorithm-driven tools for streamlined data analysis
- Key trends and technologies that will shape the future of flow cytometry
Who may this interest?
- Biotech and pharma professionals
- Flow cytometry specialists
- Regulatory and quality assurance professionals
- Lab managers and outsourcing coordinators
- Data scientists and bioinformaticians
- Clinical researchers
- Clinical operations
Speakers
Thanh-Long Nguyen
Manager of Bioanalytical Sciences
ICON
Thanh-Long Nguyen is a Manager of Bioanalytical Science at ICON. He holds a Doctorate degree in the field of Immunology from Saint Louis University School of Medicine (MO, USA). Long’s field of expertise includes flow cytometry and biomarkers and his role currently includes leading the flow cytometry method development team in Lenexa, Kansas, as well as providing scientific support to the business development and operational teams.
Virginia Litwin
President-Elect
International Society for the Advancement of Cytometry
Virginia Litwin is a thought-leader in validation and standardization focusing on “Cytometry from Bench-to-Bedside”. She is currently the President-Elect of the International Society of the Advancement of Cytometry (ISAC; DC, USA). In 2023, she received the International Clinical Cytometry Society (ICCS) Wallace H Coulter Award in recognition of her contributions to Clinical Cytometry. She is a member of the National Institute of Standards and Technology (NIST) Flow Cytometry Standards Consortium and has been an invited speaker at FDA/NIST several times.
Virginia serves on the Clinical and Laboratory Standards Institute (CLSI) Expert Panel and is the Documents Development Committee chair for the CLSI guidance documents on Validation (H62 1st Edition) and Immunophenotyping (H42 3rd Edition). She is an Editor for Cytometry Part B and has been a guest editor for special issues addressing translational cytometry. She founded the American Association of Pharmaceutical Scientists (AAPS) Flow Cytometry Committee. After obtaining a PhD in Virology/Immunology from the University of Iowa (IA, USA), Virginia joined Lewis Lanier at DNAX (CA, USA) as a post-doctoral fellow where she identified the KIR receptor, CD158E1. She was a biomarker scientist at Bristol-Myers Squibb (NJ, USA) and is currently a Director of Scientific Affairs at Eurofins Clinical Trial Solutions (KS, USA).
In association with:
